EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AWGC2023 cachexia consensus as a valuable tool for predicting prognosis and burden in Chinese patients with cancer

Hailun Xie, Lishuang Wei, Guotian Ruan, Heyang Zhang, Jinyu Shi, Shiqi Lin, Chenan Liu, Xiaoyue Liu, Xin Zheng, Yue Chen, Junqiang Chen, Hanping Shi iD

Journal of Cachexia, Sarcopenia and Muscle · 2024-10 · 15 (5) · 2084-2093

DOI: 10.1002/jcsm.13555 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 27.08.2024. Verfasst von Hailun Xie und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Gland Surgery, First Affiliated Hospital, Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Cachexia, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Young Elite Scientists Sponsorship Program by CAST, National Key Research and Development Program, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Asian Working Group for Cachexia (AWGC) proposed the first consensus report on diagnostic criteria for cachexia in Asians in 2023. However, the current consensus lacks cohort evidence to validate its effectiveness and practicality. We aimed to explore the value of the AWGC2023 criteria for predicting the prognosis and medical burden of patients with cancer through a retrospective post hoc cross‐sectional analysis of the Investigation on Nutrition Status and its Clinical Outcome of Common Cancers (INSCOC) project in China.

Methods

Cox regression analyses were performed to assess the independent association between cachexia and long‐term survival. We utilized C‐reactive protein (CRP), neutrophil‐to‐lymphocyte ratio (NLR), inflammatory burden index (IBI), albumin (ALB) and Glasgow prognostic score (GPS) as diagnostic markers for cachexia, designating them as CRP‐based cachexia, NLR‐based cachexia, IBI‐based cachexia, ALB‐based cachexia and GPS‐based cachexia, respectively. Additionally, we diagnosed cachexia using body mass index (BMI) cutoff values of 18.5, 20, 21 and 22 kg/m 2 , respectively, and subsequently compared their prognostic predictive value through Harrell's concordance index (C‐index). Logistic regression models were used to assess the association between cachexia and medical burden.

Results

A total of 5426 patients with cancer were enrolled in this study. Cox regression analysis confirmed that cachexia based on the AWGC2023 criteria was an independent predictor of long‐term survival in patients with cancer. Patients with cachexia had significantly poorer long‐term survival than patients without cachexia (66.4% vs. 49.7%, P < 0.001). Inflammatory biomarker‐based cachexia was as an independent predictor of prognosis in patients with cancer, with inflammatory burden index (IBI)‐based cachexia demonstrating the optimal prognostic discriminatory ability. The C‐index indicated that cachexia based on BMI cutoff values of 18.5, 20, and 22 kg/m 2 did not perform as well as a BMI cutoff value of 21 kg/m 2 . Logistic regression models revealed that using the AWGC2023 criteria, patients with cachexia had a 16.6% higher risk of prolonged hospitalization and a 16.0% higher risk of high medical expenses than patients without cachexia.

Conclusion

The AWGC2023 criteria represent a valuable tool for predicting survival and medical burden among Chinese patients with cancer. Encouragement for further validation in other Asian populations is warranted for the AWGC2023 criteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaNeoplasmsHumansPrognosisMaleFemaleMiddle AgedChinaAgedRetrospective StudiesConsensusBiomarkersCross-Sectional StudiesC-Reactive ProteinEast Asian People

Stichwörter der Autor:innen

AWGC2023 criteriaCancer cachexiaMedical burdenSurvival

Substanzen

BiomarkersC-Reactive Protein

Autor:innen und Institutionen

  • Department of Gastrointestinal Gland Surgery, First Affiliated Hospital, Guangxi Medical University, Nanning, China.
  • Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China.

ORCID-Profile: Hanping Shi

Förderung

  • Young Elite Scientists Sponsorship Program by CAST
  • National Key Research and Development Program
  • National Key Research and Development Program of China

Zitieren

APA

Xie, H., Wei, L., Ruan, G., Zhang, H., Shi, J., Lin, S., Liu, C., Liu, X., Zheng, X., Chen, Y., Chen, J., & Shi, H. (2024). AWGC2023 cachexia consensus as a valuable tool for predicting prognosis and burden in Chinese patients with cancer. Journal of Cachexia, Sarcopenia and Muscle, 15(5), 2084-2093. https://doi.org/10.1002/jcsm.13555

Vancouver

Xie H, Wei L, Ruan G, Zhang H, Shi J, Lin S, et al. AWGC2023 cachexia consensus as a valuable tool for predicting prognosis and burden in Chinese patients with cancer. Journal of Cachexia, Sarcopenia and Muscle. 2024;15(5):2084-2093. doi:10.1002/jcsm.13555

BibTeX
@article{Xie2024,
  author = {Xie, Hailun and Wei, Lishuang and Ruan, Guotian and Zhang, Heyang and Shi, Jinyu and Lin, Shiqi and Liu, Chenan and Liu, Xiaoyue and Zheng, Xin and Chen, Yue and Chen, Junqiang and Shi, Hanping},
  title = {AWGC2023 cachexia consensus as a valuable tool for predicting prognosis and burden in Chinese patients with cancer},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2024},
  volume = {15},
  number = {5},
  pages = {2084--2093},
  doi = {10.1002/jcsm.13555}
}
Kostenlos starten →